title: Benefits of continuous infusion epidural analgesia throughout vaginal delivery.
abstract: Two groups of nulliparous women with fetuses in singleton vertex presentation received continuous infusion epidural analgesia (EDA) with bupivacaine: group A (90 parturients) without infusion analgesia in the second stage of labor and group B (90 parturients) with infusion analgesia throughout delivery. The groups were compared regarding pain relief, duration of the second stage, persistent malrotation of the fetal head, and rate of instrumental vaginal delivery. The continuous infusion EDA gave satisfactory pain relief in 93.3% of the parturients in group A and 97.8% in group B. The duration of second stage was the same in both groups. There were more persistent malrotations of the fetal head in group A, but the malrotation did not affect the mode of delivery. The rate of instrumental vaginal delivery was 25.5% in both groups. The main cause of operative intervention was delay in the second stage. When the continuous infusion technique is used, it seems unreasonable to discontinue the EDA and thereby deprive the parturient of analgesia during the second stage.
authors.affiliation: Vestfold Central Hospital, Department of Obstetrics and Gynecology, Tønsberg, Norway.
authors.forename: M L
authors.initials: ML
authors.lastname: Johnsrud
authors.forename: P O
authors.initials: PO
authors.lastname: Dale
authors.forename: B
authors.initials: B
authors.lastname: Løvland
mesh_terms: D015360:Analgesia, Epidural / Q000379:methods*; D000773:Anesthesia, Obstetrical / Q000379:methods*; D002045:Bupivacaine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007748:Labor Stage, Second; D007743:Labor, Obstetric; D011247:Pregnancy; D011446:Prospective Studies; D011897:Random Allocation
chemical_list: D002045:Bupivacaine